CSF-Dynamics is developing a new type of hydrocephalus shunt that overcomes the major issues of current shunts on the market. The shunt is currently undergoing clinical testing. CSF-Dynamics expects the shunt to be approved for clinical use by end of year 2021.

Please contact us by email if you are interested to know more about the technology and the status of the development.

CSF-Dynamics has received a Horizon 2020 SME Phase 2 grant from the EU that supports our effort to bring the product to market as soon as possible. 

Our website is meant for communication with investors, physicians and collaborators.


Access to our website requires a password.